Table 1.
Characteristics of Indian cohort. Data presented as median (25th–75th Centile) unless otherwise stated. T1D aab positive indicates positivity for any one of 3 antibodies (GAD, IA2, ZnT8) tested. NA: Not applicable; ND: Not Done.
| Cohort | T1D aab positive | T1D (clinically defined) | T2D | Controls |
|---|---|---|---|---|
| N | 200 | 262 | 345 | 324 |
| Males (%) | 42 | 40.5 | 41.7 | 53.1 |
| Age at diagnosis (years) | 10.0 (6.9–13.4) | 9.8 (6.2–13.2) | 51.0 (47.3–55.5) | NA |
| Age at sample collection (years) | 13.9 (9.5–19.6) | 14.6(9.9–20.9) | 56.3 (51.8–61.6) | 31.4 (27.5–35.3) |
| Duration of diabetes (years) | 2.9 (0.1–7.2) | 3.6 (0.3–8.4) | 9.3 (7.0–12.7) | NA |
| BMI Kg/m2 | XX | 17.4 (15.0–19.9) | 28.0 (26.3–29.6) | 19.4 (17.6–22.0) |
| At least one Islet autoantibody [n(%)] | N/A | 200(76%) | ND | ND |
| Random C-peptide (pmol/L) | 29.0 (<3–144.7) | 22 (<3–128) | ND | ND |